Proteomics and biomarker
Proteomics and biomarker
批准号:
8260585
负责人:
RODNEY P GUTTMANN
金额:
$20.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
4 hydroxynonenalAddressAlzheimer&aposs DiseaseAmericanAmyotrophic Lateral SclerosisAnimal ModelAreaAstrocytesBehavioralBiological AssayBiological MarkersBiological ModelsBrain InjuriesCalciumCalpainCell Culture TechniquesCell DeathCellsCerebral IschemiaCerebrospinal FluidCessation of lifeCleaved cellCollaborationsDataDigestionDiseaseEffectivenessEnzymesFunctional disorderFutureGoalsHuntington DiseaseIn VitroIndividualInjuryIonophoresKnockout MiceLinkLipid PeroxidationMass Spectrum AnalysisMeasurementMeasuresMediatingMethodsMicrogliaMitochondriaModelingMonitorNatureNerve DegenerationNeurogliaNeuronal DysfunctionNeuronsOligodendrogliaOutcomeOxidation-ReductionOxidative StressParkinson DiseasePathway interactionsPeptide HydrolasesPopulationPrimary Cell CulturesPrionsProtein IsoformsProteinsProteolysisProteomicsPublishingRoleSerumSpectrinSpinal cord injurySystemTherapeuticTherapeutic InterventionTimeTraumatic Brain InjuryTreatment EfficacyTwo-Dimensional Gel ElectrophoresisWestern BlottingWorkattenuationbasebrain tissuecalpastatincell injurycell typedisabilityefficacy testingfunctional outcomesimprovedin vivoinhibitor/antagonistinsightm-calpainneurofilamentnoveloxidationpreventprogramssmall moleculetherapeutic effectivenesstherapeutic targettoolworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This Program Project focuses on the hypothesis that calpain inhibition represents a rationale and feasible
target for therapeutic intervention following TBI. Traumatic brain injury (TBI) results in more than 50,000
deaths each year with over 5 million Americans suffering the effects of some type of TBI. In addition the
need for improved therapeutics, it is important to understand the mechanisms underlying the pathological
sequelae to TBI. One area that has been implicated as an important contributor to cellular injury following
TBI is the calcium- and redox-dependent calpain/calpastatin proteolytic system. The central hypothesis of
this core is that calpain cleavage of specific proteins is linked to cell and neuronal and dysfunction following
TBI. The related hypothesis is that attenuation of this proteolysis will result in reduced degeneration and
improved functional outcome. Given the strong evidence for the role of calpains in neurodegeneration, the
long-term goal is to identify the targets of calpain that contribute to neurodegeneration following TBI. The
goals of this Core are to: 1) provide uniform assessment of calpain substrates following TBI, including celltype
specific substrates, thereby better characterizing the time-course and localization of calpain activity; 2)
identify and verify biomarkers of neurodegeneration to monitor injury progression as well as efficacy of
therapeutics, and; 3) determine the extent to which oxidative stress inhibits calpain activity over the time
course of TBI, an area that remains unexplored. In collaboration with the three projects, these core studies
will utilize 2D-gel electrophoresis, mass-spectrometry, Western blot analysis, and calpain activity assays with
brain tissue, CSF, and serum to achieve these goals. In summary, this core will provide the needed tools and
assistance for uniform analysis of calpain substrate degradation within the projects, provide additional
support for the discovery of calpain substrates and related biomarkers, and provide direct measurements of
calpain activity to determine the influence of oxidative stress on calpain activity following TBI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomics and biomarker
-
批准号:7288124
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2007
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Oxidation of cysteine-proteases in Alzheimer's Disease
-
批准号:7270125
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2006
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Oxidation of cysteine-proteases in Alzheimer's Disease
-
批准号:7103905
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2006
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Novel calpain inhibitors based on phage display
-
批准号:6893402
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2004
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Novel calpain inhibitors based on phage display
-
批准号:6823489
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2004
-
负责人:RODNEY P GUTTMANN
-
依托单位:
MODULATION OF NMDA RECEPTOR ACTIVITY BY CALPAIN
-
批准号:6351778
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:RODNEY P GUTTMANN
-
依托单位:
MODULATION OF NMDA RECEPTOR ACTIVITY BY CALPAIN
-
批准号:6055212
-
项目类别:
-
资助金额:$3.17万
-
财政年份:2000
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Proteomics and biomarker
-
批准号:7809532
-
项目类别:
-
资助金额:$19.65万
-
财政年份:--
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Proteomics and biomarker
-
批准号:8058717
-
项目类别:
-
资助金额:$20.02万
-
财政年份:--
-
负责人:RODNEY P GUTTMANN
-
依托单位:
Proteomics and biomarker
-
批准号:7614215
-
项目类别:
-
资助金额:$19.07万
-
财政年份:--
-
负责人:RODNEY P GUTTMANN
-
依托单位:
海外基金